𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer

✍ Scribed by Takafumi Toita; Shingo Kato; Satoshi Ishikura; Kayoko Tsujino; Takeshi Kodaira; Takashi Uno; Kazuo Hatano; Hideyuki Sakurai; Yuzuru Niibe; Tomoko Kazumoto; Tetsuo Nishimura; Ryo Kitagawa; Miki Fukutani; Masahiko Oguchi; Kenji Umayahara; Yasuyuki Hirashima; Yoichi Aoki; Ken Takizawa; and Disease Committee of Radiation Oncology, Japanese Gynecologic Oncology Group

Publisher
Springer
Year
2011
Tongue
English
Weight
168 KB
Volume
16
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High dose chemoradiotherapy followed by
High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction : Results of a Phase II study of the Eastern Cooperative Oncology Group
✍ Steven M. Keller; Louise M. Ryan; Lawrence R. Coia; Phuong Dang; David J. Vaught πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

## BACKGROUND. To assess the toxicity, local response, and survival associated with multimodality therapy in a cooperative group setting, patients with biopsy-proven clinical Stage I or II adenocarcinoma of the esophagus (staged according to 1983 American Joint Committee on Cancer criteria) or gast

Concurrent chemoradiotherapy with weekly
Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53)
✍ Prakash B. Chougule; Muhammad S. Akhtar; Ritesh Rathore; James Koness; Robert Mc πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 1 views

## Abstract ## Background. A phase II study was conducted using concurrent paclitaxel, carboplatin, and external beam radiotherapy (RT) in patients with advanced head and neck cancer. ## Methods. Forty‐three patients (stage III, __n__ = 12; stage IV, __n__ = 31) were treated with 8 cycles of wee